Navigation Links
Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
Date:5/20/2011

.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.  Questcor also markets Doral(R) (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. For more information, please visit www.questcor.com.

Note: Except for the historical information contained herein, this press release contains forward-looking statements that have been made pursuant to the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Our reliance on Acthar for substantially all of our net sales and profits;
  • Our ability to generate revenue from sales of Acthar to treat on-label indications associated with NS, and our ability to develop other therapeutic uses for Acthar;
  • Our ability to effectively manage our growth and our reliance on key personnel;
  • Volatility in Questcor's monthly and quarterly Acthar shipments
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
2. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
3. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
4. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
5. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
6. Questcor Pharmaceuticals Selects BDO USA as its Auditor
7. Questcor Reports 2010 Financial Results
8. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
9. Questcor Pharmaceuticals Reports Strong Finish to 2010
10. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
11. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and medical device ... and the United States , today ... Tel Aviv area of Israel.  ... broad platform of integrated R&D services to local customers. ...
(Date:10/30/2014)... -- Boston Scientific Corporation (NYSE: BSX ) ... Annual Healthcare Conference on Tuesday, November 11, 2014 in ... , executive vice president and chief financial officer, will ... 8:00 a.m. PT followed by a question and answer ... and question and answer session will be available to ...
(Date:10/30/2014)... 2014   ViaDerma, Inc. (OTCQB: VDRM), ... products to market, has recently released a revolutionary ... a topical liquid tetracycline-based antibiotic that uses a ... oral medication active ingredients into topical drugs. The ... antibiotic to help prevent skin infection in minor ...
Breaking Medicine Technology:WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... is scheduled to present at the 23rd Annual Piper Jaffray ... and 30th at The New York Palace in New York ... on December 1, 2011 at Island Shangri-La Hotel, Hong Kong. ...
... (Nasdaq: ISIS ), the leader in antisense therapeutics, ... Piper Jaffray,s Health Care Conference on Wednesday, November ... Palace. A live audio webcast of the presentation ... the Company,s Web site, www.isispharm.com . A replay of ...
Cached Medicine Technology:Sinovac to Present at 23rd Annual Piper Jaffray Health Care Conference and HK/China Mini Conference 2011 (Healthcare) 2
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, ... genes have been identified that appear linked to autism ... say they are on their way to discovering up ... disorder. Autism spectrum disorders include a range of ... repetitive behaviors. An estimated one in 68 U.S. children ...
(Date:10/30/2014)... FL (PRWEB) October 30, 2014 ... offering therapeutic horseback riding to special needs individuals in ... Round-Up on Saturday, November 15 from 10-2:00 p.m. at ... event is open to the public and is designed ... , Admission to the HSS Round-Up is free. ...
(Date:10/30/2014)... The human brain is often overlooked ... to help maintain better mental health, according to Dr. ... Lose Your Memory in 100 Ways’ for just that ... conflicting attitudes to help keep the reader constantly thinking. ... must decipher the hidden logic within. , “If you ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- When it comes ... likely than men to delay care when they have symptoms ... someone comes to the hospital with a more severe or ... options available," study author Catherine Kreatsoulas, a Fulbright Scholar and ... in a news release from the Heart and Stroke Foundation ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- Many ... near campus, even though tanning increases the risk ... popular among young adults, particularly white women, so ... students, health, the researchers said. "Public health ... student population awareness of the harms that indoor ...
Breaking Medicine News(10 mins):Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... A University of Missouri researcher has found that ... increases satiety and reduces hunger throughout the day. In ... found that eating a protein-rich breakfast reduces the brain ... "Everyone knows that eating breakfast is important, but many ...
... reduced inflammation in Crohn,s patients in a research ... Crohn,s disease is a chronic inflammatory condition of ... bleeding and weight loss. Treatments for Crohn,s disease ... be associated with rare but serious side effects, ...
... studies on whether moderate exercise can curb the nicotine ... apparent contradiction: it seems to work in short-term, well ... trials. A new study may explain why and help ... in the results of research led by David Williams, ...
... little more difficult now that French researchers have discovered ... seriously compromised during long-term space flight. In a new ... ( http://www.fasebj.org ), the scientists show that antibodies produced ... terra firma. The reduced effectiveness of antibodies makes astronauts ...
... is a major problem for society behind only headaches as ... degeneration of the intervertebral disc. Researchers have worked for many ... on the lower back. Now, in results published in ... permanently replace the workings of the invertebral disc. It is ...
... , THURSDAY, May 19 (HealthDay News) -- Problem ... availability, especially online, of gambling opportunities, said experts who ... of the disorder. While most people gamble as ... become too seriously involved in terms of time invested ...
Cached Medicine News:Health News:Eat a protein-rich breakfast to reduce food cravings, prevent overeating later, researcher finds 2Health News:Use of naltrexone reduces inflammation in Crohn's patients 2Health News:Exercise helps women fight smoking cravings, but effect is short-lived 2Health News:Antibody production gets confused during long-term spaceflight 2Health News:Implant jab could solve the misery of back pain 2Health News:Internet Is Playing a Part in Spread of Problem Gambling 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: